Factors affecting liver regeneration after right portal vein embolization

Hepato-Gastroenterology

Volumn 51, Issue 56, 2004, Pages 532-535

  Kusaka, Koji ^a   Imamura, Hiroshi ^a   Tomiya, Tomoaki ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Nonembolized liver; Portal vein embolization; Transforming growth factor

Indexed keywords

AMIKACIN; GELFOAM; MEGLUMINE DIATRIZOATE; THROMBIN; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER BLOOD FLOW; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER REGENERATION; MALE; PORTAL VEIN; PORTAL VEIN EMBOLIZATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; EMBOLIZATION, THERAPEUTIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATECTOMY; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE PERIOD; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 1842430898     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rous P, Larimore L: Relation of the portal blood to liver maintenance. J Exp Med 1920; 31:609-632.
2. Schalm L, Bax H, Mansence B: Atrophy of the liver after occlusion of the bile ducts or portal vein and compensatory hypertrophy of the unoccluded portion and its clinical importance. Gastroenterology 1956; 31:131-155.
3. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, Hasegawa H, Ozaki H: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107:521-527.
4. Azoulay D, Raccuia JS, Castaing D, Bismuth H: Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg 1995; 181:266-269.
5. Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, Sugihara K, Moriya Y: Resection for multiple metastatic liver tumors after portal embolization. Surgery 1994; 115:674-677.
6. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Hayakawa N, Yamamoto H: Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995; 21:434-439.
7. Baere T, Roche A, Vavasseur D, Therasse E, Indushekar S, Elias D, Bongel C: Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology 1993; 188:73-77.
8. Fausto N: Hepatic regeneration. In: Zakim D, Boyer TD (Eds.). Hepatology. Vol I, Philadelphia: W.B. Saunders, 1996; pp. 32-57.
9. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997; 276:60-66.
10. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT: TGF-α overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990; 61:1137-1146.
11. Webber EM, Godowski PJ, Fausto N: In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994; 14:489-497.
12. Mead JE, Fausto N: Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989; 86:1558-1562.
13. Russel WE, Dempsey PJ, Sitaric S, Peck AJ, Coffey RJ Jr: Transforming growth factor-a (TGF α) concentrations increase in regenerating rat liver: evidence for a delayed accumulation of murine TGF α. Endocrinology 1993; 133:1731-1738.
14. Webber EM, FitzGerald MJ, Brown PI, Bartlett MH, Fausto N: Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology 1993; 18:1422-1431.
15. Tomiya T, Ogata I, Fujiwara K: Transforming growth factor α levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am J Pathol 1998; 153:955-961.
16. Tomiya T, Fugiwara K: Serum levels of transforming growth factor-alpha in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Hepatology 1993; 18:304-308.
17. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T: Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors Hepatology 1997; 26:1176-1181.
18. Goto Y, Nagino M, Nimura Y: Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization. Ann Surg 1998; 228:209-213.
19. Tomiya T, Fujiwara K: Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor α levels. Hepatology 1996; 23:253-257.
20. Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R: Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 1993; 17:109-115.
21. Harada H, Imamura H, Miyagawa S, Kawasaki S: Fate of the human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study. Hepatology 1997; 26:1162-1170.
22. Starzl T, Francavilla A, Halgrimson C: The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surgery, Gynecol Obstet 1973; 137:179-199.
23. Baere TD, Roche A, Elias D, Lasser P, Lagrange C, Bousson V: Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 1996; 24:1386-1391.